KLF9 is a potent growth suppressor in prostate cancer cell lines in vitro and this involves, in part, the repression of two major pathways, namely those for AKT and the androgen receptor (AR), along with the induction of apoptosis [86,228]. This evidence concerns the gene KLF9 and prostate carcinoma.